Kinetic variable most useful for identifying malignant MRI-detected breast lesions identified

	Tweet

Breast MRI allows physicians to evaluate suspicious lesions using a variety of variables. Researchers have found though that computer-aided kinetic information can help significantly in distinguishing benign from malignant suspicious breast lesions on MRI, according to a study published in the September issue of the American Journal of Roentgenology (AJR).

In the study, performed at the University of Washington Medical Center, researchers analyzed and compared the computer-aided evaluation variables of 125 suspicious breast lesions. Three different kinetic curves (washout, plateau and persistent), were compared along with lesion morphology (size and shape). “We wanted to clarify which, of the many variables that reflect kinetics, were most predictive of malignancy, said Constance Lehman, MD, lead author of the study. “We found overlap in kinetic patterns across benign and malignant lesions, but we did determine that the “most suspicious” curve type, washout, was useful in separating benign from malignant lesions,” said Dr. Lehman.

“Of lesions with the most suspicious curve type (any washout), 45.7 percent were malignant compared with 20.0 percent with plateau and 13.3 percent with entirely persistent enhancement,” she said. 

"We continue to study the specific features on MRI most predictive of breast cancer. We know that the morphology of the lesion is extremely important, but our study also supports the use of kinetic features in lesion assessment. The “most suspicious” curve, washout, does seem to help distinguish benign from malignant lesions,” said Dr. Lehman.

“In breast MRI, it is important to know which variables are most important for predicting malignancy because they help us in determining whether or not a lesion needs to be biopsied or not,” she said.

###

This study appears in the September issue of the American Journal of Roentgenology. For a copy of the full study, please contact Heather Curry via email at or at 703-390-9822.

About ARRS
The American Roentgen Ray Society (ARRS) was founded in 1900 and is the oldest radiology society in the United States. Its monthly journal, the American Journal of Roentgenology, began publication in 1906. Radiologists from all over the world attend the ARRS annual meeting to participate in instructional courses, scientific paper presentations and scientific and commercial exhibits related to the field of radiology. The Society is named after the first Nobel Laureate in Physics, Wilhelm Röentgen, who discovered the x-ray in 1895.

Contact: Heather Curry

703-390-9822
American Roentgen Ray Society

RELATED STORIES:
Plant-focused diet may curb breast cancer risk   Radiation Beneficial for Older Breast Cancer Patients   Gene therapy kills breast cancer stem cells, boosts chemotherapy   Air Pollution Exposure Affects Chances of Developing Premenopausal Breast Cancer   Biopsy of Recurrent Breast Cancer Can Alter Treatment   Researchers Identify Risk Factors for Contralateral Breast Cancer   Inflammatory Breast Cancer More Rare, More Lethal than Common Form   Breast reconstruction can have lasting benefits   Blood thinners like aspirin may fight cancer: study   Study links breast cancer risk to epigenetic changes related to race, smoking and birth size   Estrogen receptor-alpha, breast cancer patients and tamoxifen response   Therapy may block expansion of breast cancer cells   Minorities less likely to know about breast cancer options   Intake of Vitamin D, Calcium Associated With Lower Risk of Breast Cancer Before Menopause   Local Therapy and Survival in Breast Cancer   Breast cancer pain more severe in non-whites   Spanish scientists confirm extra virgin olive oil helps to combat breast cancer   First prospective analysis links breast and pancreatic cancer risk with lynch syndrome   Activity key to breast cancer patients’ survival   FDA Broadens Clearance For Agendia’s MammaPrint(R)   Physicians validate reclassification of breast cancer stages   Scientists Test New Drug Combo Against Breast Cancer

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]